Chinese Regulators, Police Intensify Investigation Of Vaccine Producer For Possible Malfeasance, Cover-up

BEIJING - Leading Chinese drug maker Simcere Pharmaceutical has revealed that certain personnel at recently acquired vaccine producer Jiangsu Yanshen Biological Technology are under investigation for possible attempts to cover up lapses in good manufacturing practice standards that led to the release of substandard rabies vaccine doses in 2008